Porsolt expands with the acquisition of Fluofarma

Latest Posts

OSE Immunotherapeutics announces manufacturing agreement with Cenexi for clinical batches of CoVepiT, OSE’s multi-target second-generation COVID-19 vaccine

30 June 2021

OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), today announced the signature of an agreement whereby... View Article

GlioCure strengthens its management team with the recruitment of Dr. Sandrine Courtès as Director of Preclinical Development and Intellectual Property

29 June 2021

GlioCure SA, a biotechnology company specializing in neuro-oncology, announces the arrival of Dr. Sandrine Courtès, a researcher-entrepreneur dedicated to brain... View Article

InFlectis BioScience licenses rights to a potential new class of therapies for demyelinating diseases from the University of Chicago

22 June 2021

InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment... View Article

« Previous 1 … 50 51 52 53 54 … 160 Next »